News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Schwartz Jonathan David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/22/2023 |
4
| Schwartz Jonathan David (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 3,557 shares
@ $19.06, valued at
$67.8k
|
|
| 02/22/2023 |
4/A
| Schwartz Jonathan David (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 124,496 options to buy
@ $20.04, valued at
$2.5M
Granted 41,541 restricted stock units
@ $0
Exercised 8,574 options to buy
@ $0 |
|
| 09/15/2022 |
4
| Schwartz Jonathan David (Director) has filed a Form 4 on Tabula Rasa HealthCare, Inc.|
Txns:
| Granted 52,747 shares
@ $0 |
|
| 09/15/2022 |
3
| Schwartz Jonathan David (Director) has filed a Form 3 on Tabula Rasa HealthCare, Inc. |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4/A
| Schwartz Jonathan David (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 10,562 shares
@ $15.94, valued at
$168.4k
Sold 34,438 shares
@ $16.56, valued at
$570.3k
Sold 9,002 shares
@ $15.9, valued at
$143.1k
Sold 35,998 shares
@ $16.15, valued at
$581.4k
Sold 12,974 shares
@ $15.86, valued at
$205.8k
Sold 32,026 shares
@ $16.2, valued at
$518.8k
|
|
| 04/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Schwartz Jonathan David (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 81,010 options to buy
@ $20, valued at
$1.6M
Granted 25,984 restricted stock units
@ $0 |
|
| 02/08/2021 |
4
| Schwartz Jonathan David (Chief Medical Officer) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 35,000 options to buy
@ $62.32, valued at
$2.2M
|
|
| 02/03/2021 |
4
| Schwartz Jonathan David (Chief Medical Officer) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 11,428 shares
@ $1.69, valued at
$19.3k
Exercised 213,101 shares
@ $1.21, valued at
$257.9k
Disposed/sold 11,428 options to buy
@ $1.69, valued at
$19.3k
Disposed/sold 213,101 options to buy
@ $1.21, valued at
$257.9k
|
|
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2019 |
4
| Schwartz Jonathan David (Chief Medical Officer) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $10.85, valued at
$325.5k
|
|
| 01/30/2019 |
4
| Schwartz Jonathan David (Chief Medical Officer) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 75,000 options to buy
@ $14.56, valued at
$1.1M
|
|
| 04/02/2018 |
4
| Schwartz Jonathan David (Chief Medical Officer) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 60,000 options to buy
@ $18.75, valued at
$1.1M
|
|
| 01/16/2018 |
3
| Schwartz Jonathan David (Chief Medical Officer) has filed a Form 3 on ROCKET PHARMACEUTICALS, INC. |
|
|